Cargando…
The Seroprevalence of COVID-19 in Intravenous Drug Users in Comparison to Non-drug Users
BACKGROUND COVID-19 infection has led to a worldwide pandemic, and new cases are on the rise. Intravenous drug users (IVDU) are presumably at a higher risk of being infected since they have poor personal hygiene, live in groups, and have risky behaviors. The current study aimed to evaluate the serop...
Autores principales: | Mohammadi, Zahra, Eghtesad, Sareh, Hashemi-Shahri, Seyed Mohammad, Tabatabaei, Seyed Mehdi, Sharafkhah, Maryam, Poustchi, Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Association of Gastroerterology and Hepatology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531943/ https://www.ncbi.nlm.nih.gov/pubmed/34712441 http://dx.doi.org/10.34172/mejdd.2021.206 |
Ejemplares similares
-
Incarceration is a major risk factor for blood-borne infection among intravenous drug users: Incarceration and blood borne infection among intravenous drug users
por: Mir-Nasseri, Mohammad Mehdi, et al.
Publicado: (2011) -
Seroprevalence Study of Hepatitis C and Hepatitis B Virus among Hospitalized Intravenous Drug Users in Ahvaz, Iran (2002-2006)
por: Alavi, Seyed Mohammad, et al.
Publicado: (2010) -
Seroprevalence of hepatitis B markers among incarcerated intravenous drug users
por: Nokhodian, Zary, et al.
Publicado: (2014) -
Hepatitis C Genotypes Distribution in Intravenous Drug Users in Tehran
por: Alavian, Seyed Moayed
Publicado: (2015) -
Negative Association of Plasma Levels of Vitamin D and miR-378 With Viral Load in Patients With Chronic Hepatitis B Infection
por: Mohamadkhani, Ashraf, et al.
Publicado: (2015)